S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › ZAL › Research report
← ZAL page
XStocksXray
Market X-Ray report · 19 October 2026

Zarea Limited (ZAL)

Karachi Stock Exchange · Pakistan · prices in PKR · close of 19 Oct 2026

Key indicators

Last closePKR 39.06
52-week range35.87 – 79.50
Return, 1 month / 3 months+0.4% / −0.9%
Return, 1 year / 3 years−1.0% / –
TrendBelow its 200-day average
RSI (14)49
Volatility (1 year)61.5%
Worst drawdown (1 year)-49.4%
Average daily value traded26.49M PKR
Dividend yield–

Market X-Ray price-based

36/ 100 · High confidence · ahead of 21% of stocks on this exchange
Trend12
Momentum45
Stability (higher is calmer)31
Liquidity72
Income–

Fair value limited data

Average of 3 modelsPKR 46.39Model uncertainty High
Versus priceUndervalued+19% to fair value

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

10.4626.7943.1359.4775.80Fair value $462025-022025-072025-122026-052026-10

Summary

Zarea Limited (ZAL) trades on the Karachi Stock Exchange in Pakistan. It last closed at PKR 39.06 on 19 October 2026.

Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 388 of 491 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 1.0% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.

Our limited-data fair value is PKR 46.39 (Undervalued, +18.8% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.

stocksxray.com · page 1
XStocksXray
Zarea Limited (ZAL)

The five lenses in numbers each metric is ranked against the other stocks on Karachi Stock Exchange

Lens and metricValueScoreReading
Trend12 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-16.3%
From 52-week high-46.0%
Momentum45 · WeakLagging most stocks on this exchange.
3-month return-0.9%
6-month return-13.8%
12-month return, skipping the last month-1.3%
Stability (higher is calmer)31 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)61.5%
Worst drawdown, 1 year (smaller is calmer)-49.4%
Liquidity72 · StrongTrades actively.
Average daily value traded26.49M PKR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+2.6%
1 month+0.4%
3 months−0.9%
6 months−13.8%
1 year−1.0%
3 years–
5 years–

Signals

50-day / 200-day average39.83 / 46.65
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.45

Technical summary

DailyBearish2 bullish · 4 neutral · 10 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 7 bearish
MonthlyBearish1 bullish · 1 neutral · 3 bearish

Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built

P/E multiplePKR 48.87
P/S multiplePKR 43.75
P/E on average earningsPKR 46.56

How to read this report

Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Karachi Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026